The decidua-the maternal bed embracing the embryo-maintains the pregnancy
These patients had newly filled prescriptions for GLP-1 RAs, dipeptidyl peptidase-4 (DPP4) inhibitors, sodium-glucose cotransporter 2 (SGLT2) inhibitors or sulfonylurea between January 2014 and December 2021
[DOI] [PMC free article] [PubMed] [Google Scholar] 61.Klausen M.K., Jensen M.E., Moller M., Le Dous N., Jensen A.O., Zeeman V.A., Johannsen C.F., Lee A., Thomsen G.K., Macoveanu J., et al
The combined clinical benefits and mechanistic insights position GLP-1RAs as leaders in addressing glycemic dysregulation and liver diseases, suggesting a transformative approach to the association between metabolic disorders and liver conditions
La interrupcin del tratamiento con agonistas de GLP-1R antes de la operacin puede provocar un empeoramiento de la glucemia y una inestabilidad metablica